About us

McRoberts is an innovative and flexible organization with 25 years of experience, and one of the leaders in ambulatory monitoring of physical activity. We apply our knowledge of human movement and analysis of sensor data to facilitate simple solutions in healthcare, clinical studies and research for evaluating physical functioning. Founder and former CEO of McRoberts is Rob van Lummel. His interest in the combination of movement, technology and ICT resulted in the foundation of McRoberts in 1988. In cooperation with scientific partners, epoch-making work has been realized in the development of ambulatory monitoring of physical activity. His wife, Corinne Meurs, who has been an active physiotherapist, joined the company as VP in 2006. In September 2018, after leading our company successfully for 30 years, Rob and Corinne have decided to withdraw from daily management. A young and dynamic team has taken over and will maintain our tradition of continuous improvement and development.

Testimonials

This is what our customers and partners say about us ...

"McRoberts is a very important partner of the UMCM regarding the MyoMobile study, an intervention study on the effects of physical activity on myocardial and vascular function in patients with heart failure.", says Philipp Wild, Professor of Clinical…

Read full testimonial

Univ.-Prof. Dr. med. Philipp Wild, M.Sc.

McRoberts is an important partner for many of our translational research projects”, says Kim Delbaere, Principal Research Scientist – Falls, Balance and Injury Research Centre – at Neuroscience Research Australia. “Our research focus is on…

Read full testimonial

Kim Delbaere, PhD

Our group has been collecting data from community-dwelling older adults using devices made by McRoberts for more than 5 years”, says Aron Buchman, Professor of Neurological Sciences, Rush Alzheimer's Disease Center in Chicago. “It has been a…

Read full testimonial

Aron Buchman, MD

McRoberts is a very important partner for The Hague University of Applied Sciences”, says Willem Looije, Program Manager (The Netherlands). “Since the beginning in 1992, students of our program Human Kinetic Technology are learning and working…

Read full testimonial

Willem Looije

For several years McRoberts and I are collaborating in neuromuscular and aging research,” says Andrea Maier, Professorial Fellow Medicine and Aged Care, University of Melbourne, Australia & Hoogleraar veroudering, Vrije Universiteit Amsterdam.…

Read full testimonial

Andrea Maier, PhD, MD

As the Scientific Coordinator of Moving Beyond, I would like to express my gratitude to Dr. Rob van Lummel and the McRoberts company, for their obviously extensive engagement in the network,” says Walter Maetzler, Department for Neurodegenerative…

Read full testimonial

Walter Maetzler, PhD, MD

I read your paper in PLOS One, based on measurements made with the DynaPort MoveMonitor. Very nice work and a substantial advance in the field…

Read full testimonial

Richard Casaburi, PhD, MD

Since 2012 we have collected over 1000 weeks of gait and activity of daily living data using McRoberts devices with excellent (99%) compliance,” says Professor Stephen Lord, Senior Principal Research Fellow – Falls, Balance and Injury Research…

Read full testimonial

Stephen Lord, PhD

I began working with McRoberts in 2010, finally finding first rate engineers who also were provoked because objective measures of physical activity were not common in clinical research studies for regulatory approval of new therapies,” says Stephen… I began working with McRoberts in 2010, finally finding first rate engineers who also were provoked because objective measures of physical activity were not common in clinical research studies for regulatory approval of new therapies,” says Stephen Raymond, Chief Scientist, eCOA at ERT.

“Rob van Lummel independently worked with thought leaders in COPD and other diseases where the disease limits physical activity to arrive at clinically relevant measures”, Raymond continues. “The underlying issue concerned how to interpret accelerometric data to measure the clinical benefit conferred by a treatment. One could show a variety of changes in physical activity, but how to identify objective changes that were clear indications that patients felt better? Rob understood the importance of the question, and applied the recommendations in the FDA Final Guidance on Patient Reported Outcome Measures distinguish domains in physical activity related to capability and behavior. This culminated in a wonderful scientific paper.” (http://bit.ly/2aMsmr7)

“The paper shows how clearly McRoberts appreciates the need in clinical applications for measures that have been shown to matter in the evaluation of treatments,” adds Raymond. I think that is why McRoberts’ approach to physical activity measures was incorporated by the scientific team engaged in a multimillion Euro project to develop an instrument for COPD that included key subjective PRO assessments together with objective measures of physical activity in dimensions considered most relevant by the patient.”

“Relationships underlie collaborations that result in deeper understanding of scientific questions and related opportunities in engineering and medicine, says Raymond. “My experience with McRoberts has greatly extended my appreciation for the potential and difficulties for incorporating physical activity measures into clinical investigations. It has been illuminating as well as a pleasure to work together to understand how clinical benefits can be proven using physical activity measures. Clinical investigations will ultimately be better and more convincing when they incorporate the appropriate measures of physical activity.”

Raymond concludes, “Thanks largely to McRoberts and their physician collaborators such measures now exist, and our company has found that they can feasibly be integrated with subjective assessments in pivotal phase 3 studies.

Read full testimonial

Stephen Raymond, PhD

We love to work with McRoberts for their outstanding products and services in the area of assessment of physical functioning both in health as in patients with pulmonary diseases,” says Dr. Alex van ‘t Hul, Managing Director COPDnet, Radboudumc…

Read full testimonial

Alex van ‘t Hul, PhD

In the field of activity assessment, McRoberts was known to us from the IMI PROactive project as having a genuine scientific interest in activity assessment and openness to get involved in development of new measures and principles,” says Alan…

Read full testimonial

Alan Hamilton, PhD

2019-2024

IMI Mobilise-D

2017-2020

PLAYTIME - AAL Programme

2017-2018

McRoberts is partner in COPD Foundation’s CBQC

2014-2016

COPD trial run by a global, science-led biopharmaceutical

2014

COPD trial run by an international company based in Italy

2013-2016

E-NO FALLS

2013-2015

Boehringer Ingelheim - PHYSACTO 1237.16

2012-2016

Moving Beyond

2011-2016

PROactive COPD

2010-2015

FARAO

2019-2024 IMI Mobilise-D

The title of the five-year project is ‘Linking digital assessment of mobility to clinical endpoints to drive regulatory acceptance and clinical practice’.

Read more All projects

2017-2020 PLAYTIME - AAL Programme

PLAYTIME: A serious game for people suffering from dementia.

Read more All projects

2017-2018 McRoberts is partner in COPD Foundation’s CBQC

In 2017 the Physical Activity Working Group is established, as part of the COPD Biomarker Qualification Consortium (CBQC). The Biomarkers Consortium is created

Read more All projects

2014-2016 COPD trial run by a global, science-led biopharmaceutical

he DynaPort MoveMonitor was used in a Phase IV pharmaceutical trial to search for the efficacy of a COPD drug.

Read more All projects

2014 COPD trial run by an international company based in Italy

The MoveMonitor was used in a Phase IIb pharmaceutical trial to evaluate the efficacy and safety of a medication for the treatment of patients with COPD.

Read more All projects

2013-2016 E-NO FALLS

The main goal of E-NO FALLS network is to integrate and bring together knowledge, experiences and best practices acquired in the area of fall prevention.

Read more All projects

2013-2015 Boehringer Ingelheim - PHYSACTO 1237.16

Clinical trial to explore, inter alia, the effect of bronchodilator therapy on physical activity levels in patients with COPD

Read more All projects

2012-2016 Moving Beyond

Assessment of gait and sway parameters under convenient and challenging conditions to investigate preclinical and progression parameters of Parkinson’s disease.

Read more All projects

2011-2016 PROactive COPD

The PROactive project develops and validates PRO tools to investigate dimensions of physical activity that are judged as being essential by patients.

Read more All projects

2010-2015 FARAO

In this project a unique innovative system to support fall prevention in extramural care will be developed and tested.

Read more All projects

Team

Martijn Niessen, PhD Chief Executive Officer

Jordi Evers, MSc Chief Marketing Officer

Erik Ainsworth, MSc Senior Software Engineer

Sietze de Haan, MSc Software Engineer

Neall Mouthaan, BSc Project Manager

Ali Tabasi, MSc Software Engineer

Rens van Leeuwen, MSc Allround Support Engineer

Events

You can find us at the following events. Feel free to visit our booth (indicated with the icon).

Upcoming

Past

Publications

The MoveMonitor and MoveTest are widely used in fundamental and clinical research. Three recent studies are presented below. Browse our full list of peer-reviewed publications here.

Show all publications